Koyfin Home > Directory > Health Care > Amag Pharmaceuticals > Capital Expenditures

Amag Pharmaceuticals Capital Expenditures Chart (AMAG)

Amag Pharmaceuticals annual/quarterly Capital Expenditures from 2010 to 2020.
  • Amag Pharmaceuticals Capital Expenditures for the quarter ending June 06, 2020 was $0m a 0.00% increase of 0m year over year
  • Amag Pharmaceuticals Capital Expenditures for the last 12 months ending June 06, 2020 was $-1m a -285.67% increase of 2m year over year
  • Amag Pharmaceuticals Annual Capital Expenditures for 2019 was $-3m a 0.39% decrease of 0m from 2018
  • Amag Pharmaceuticals Annual Capital Expenditures for 2018 was $-3m a -254.70% increase of 6m from 2017
  • Amag Pharmaceuticals Annual Capital Expenditures for 2017 was $-9m a 39.25% decrease of -4m from 2016
Other Cash Flow Metrics:
  • Amag Pharmaceuticals Cash Flow from Operations for the quarter ending December 12, 2018 was $-34m a 162.36% decrease of -55m year over year
  • Amag Pharmaceuticals Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-31m a 66.13% decrease of -21m year over year
  • Amag Pharmaceuticals Total Revenue for the quarter ending September 09, 2018 was $122m a -29.53% decrease of -36m year over year
View Chart On Koyfin

Quarterly AMAG Capital Expenditures Data

06/2020$0m
03/2020$0m
12/2019$0m
09/2019$0m
06/2019$0m
03/2019$-2m
12/2018$-1m
09/2018$0m
03/2018$-1m
12/2017$-2m

Annual AMAG Capital Expenditures Data

2019$-3m
2018$-3m
2017$-9m
2016$-5m
2015$-1m
2014$0m
2012$0m
2011$-1m
2010$-1m